| Summary A total of  150 female Swiss mice were used to study the ability of water soluble  propolis derivatives (WSPD) of Egyptian propolis to inhibit the proliferation  and growth of Ehrlich ascites carcinoma (EAC) cells in mice. The mice were  divided equally into three groups: the first was kept as a negative control  group, the second received an intraperitoneal injection of 2.5 × 106 EAC and was kept as a  positive control group and the third an intraperitoneal injection of 2.5 × 106 EAC and treated with  propolis (50 mg/kg body weight) administered by gastric intubations  2 h prior to the intraperitoneal injection of EAC. The propolis was  administered daily for 11 successive days. An examination of EAC cells  revealed a reduction in the volume, total cell count, viable percentage and  increase in the percentage of dead cells in the treated group with an  increasing mean survival time (MST), increasing life span (ILS) percentage and  treated vs positive control (T/C) percentage. Immunological studies revealed a  significant increase in the lymphocyte transformation rate (LTR), phagocytic  activity and killing power in the group treated with propolis. A haematological  study of the parameters revealed leucocytosis in cancer-bearing mice and propolis-treated  groups with granulocytosis and monocytosis. The erythrogram revealed a  significant reduction in red blood cell (RBC) count in group 2. The result  showed that the implantation of EAC in Swiss mice without treatment resulted in  a significant decrease in total protein and albumin levels without a change in  globulin level and a significant increase in creatinine level, while the third  group that received propolis showed an improvement in these biochemical  parameters compared to the normal control group.
 KeywordsBiochemical,  Cancer, Ehrlich ascites carcinoma, Egypt, Haematology, Immunology, Lymphocyte  transformation rate, Propolis, Water soluble propolis derivative.
 |